The authors found that subjects with AD traits had a characteristic hypomethylation status in BIN1, independent of the ApoE4 genotype, and also showed higher p-tau levels and lower CSF levels of an important AD biomarker, Aβ42, compared to the control group [136]. The gene discussed is MAPT; the disease is Alzheimer disease.